BlackRock’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,666,347
| Closed | -$137M | – | 5570 |
|
|
2023
Q1 | $137M | Buy |
5,666,347
+86,743
| +2% | +$2.09M | ﹤0.01% | 1807 |
|
|
2022
Q4 | $59M | Buy |
5,579,604
+549,256
| +11% | +$5.81M | ﹤0.01% | 2326 |
|
|
2022
Q3 | $22.6M | Buy |
5,030,348
+424,311
| +9% | +$1.91M | ﹤0.01% | 2923 |
|
|
2022
Q2 | $18.4M | Buy |
4,606,037
+214,287
| +5% | +$857K | ﹤0.01% | 3067 |
|
|
2022
Q1 | $32.1M | Sell |
4,391,750
-92,175
| -2% | -$675K | ﹤0.01% | 2812 |
|
|
2021
Q4 | $25.2M | Sell |
4,483,925
-6,801
| -0.2% | -$38.2K | ﹤0.01% | 3084 |
|
|
2021
Q3 | $28.7M | Sell |
4,490,726
-56,421
| -1% | -$361K | ﹤0.01% | 2998 |
|
|
2021
Q2 | $38.3M | Buy |
4,547,147
+84,038
| +2% | +$708K | ﹤0.01% | 2825 |
|
|
2021
Q1 | $46.8M | Buy |
4,463,109
+537,620
| +14% | +$5.64M | ﹤0.01% | 2621 |
|
|
2020
Q4 | $66.5M | Buy |
3,925,489
+611,338
| +18% | +$10.4M | ﹤0.01% | 2267 |
|
|
2020
Q3 | $42.5M | Buy |
3,314,151
+428,534
| +15% | +$5.5M | ﹤0.01% | 2343 |
|
|
2020
Q2 | $40.7M | Buy |
2,885,617
+2,203,387
| +323% | +$31.1M | ﹤0.01% | 2352 |
|
|
2020
Q1 | $6.28M | Buy |
682,230
+25,299
| +4% | +$233K | ﹤0.01% | 3186 |
|
|
2019
Q4 | $9.79M | Buy |
656,931
+173,917
| +36% | +$2.59M | ﹤0.01% | 3212 |
|
|
2019
Q3 | $3.3M | Buy |
483,014
+157,323
| +48% | +$1.07M | ﹤0.01% | 3558 |
|
|
2019
Q2 | $3.94M | Buy |
325,691
+301,052
| +1,222% | +$3.64M | ﹤0.01% | 3543 |
|
|
2019
Q1 | $57K | Sell |
24,639
-1,596
| -6% | -$3.69K | ﹤0.01% | 4413 |
|
|
2018
Q4 | $46K | Buy |
26,235
+5,472
| +26% | +$9.6K | ﹤0.01% | 4444 |
|
|
2018
Q3 | $84K | Buy |
+20,763
| New | +$84K | ﹤0.01% | 4415 |
|